Molecular Immunology Unit
The Molecular Immunology Unit at ICH researches into the molecular basis of primary immunodeficiency disorders, and other related haematopoietic disorders, and is developing improved forms of treatment. One such form of treatment is somatic gene therapy, which has become a reality with the initiation of clinical trials for three life-threatening primary immunodeficiency disorders.
The Unit comprises over 50 basic and clinical scientists, ranging from laboratory research assistants and graduate students to Consultant Immunologists and Professors. All scientists work as part of a team on one or more problems related to the theme of our research.
Professor Christine Kinnon, head of the Molecular Immunology Unit, is theme leader for Infection and Immunity.
Page last modified on 20 jun 11 12:48